Fidelity Disruptive Medicine ETF Rating $24.31 +0.66 (+2.79%) Closing price 05/2/2025 03:50 PM EasternExtended Trading$24.28 -0.04 (-0.14%) As of 05/2/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Fidelity Disruptive Medicine ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FMED Aggregate RatingModerate Buy 2.83Holdings in FMED have an aggregate rating of Moderate Buy based on 704 analyst ratings issued in the past year covering 46 companies (88.4% of the portfolio).FMED Aggregate Price Target$24.31High Prediction$24.31Average Prediction$24.31Low Prediction$24.31Holdings in FMED have an aggregate price target of $24.31 and a range of $24.31 to $24.31 covering 46 companies (88.4% of the portfolio).FMED Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy11 Buy rating(s)Moderate Buy33 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Fidelity Disruptive Medicine ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 46 FMED Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.28%BSXBoston Scientific$104.94+1.7%4.1212 of 5 stars3.04$114.52 9.1%23Positive News3.83%ISRGIntuitive Surgical$529.42+2.4%4.6862 of 5 stars2.75$598.95 13.1%20Insider TradeNews CoveragePositive News3.82%ARGXargenx$649.67+1.5%2.5193 of 5 stars2.91$699.28 7.6%23Upcoming EarningsPositive NewsGap Up3.58%PENPenumbra$295.97+1.4%4.2015 of 5 stars2.88$302.40 2.2%17Positive NewsGap Up3.39%UNHUnitedHealth Group$398.72-0.5%4.9539 of 5 stars2.92$596.86 49.7%24Analyst RevisionHigh Trading Volume3.38%DHRDanaher$199.15+1.2%4.9413 of 5 stars2.80$264.40 32.8%20Short Interest ↑3.29%WAYWaystar$40.68+3.1%2.9935 of 5 stars3.08$40.08 -1.5%13Earnings ReportPositive News3.18%PODDInsulet$257.01+2.7%4.4917 of 5 stars2.76$293.94 14.4%17Upcoming EarningsAnalyst DowngradeNews Coverage3.05%ALNYAlnylam Pharmaceuticals$259.39+1.7%4.0953 of 5 stars2.77$319.17 23.0%26Earnings ReportAnalyst DowngradeNews Coverage2.93%VEEVVeeva Systems$236.63+2.0%3.6675 of 5 stars2.52$254.92 7.7%25Positive News2.89%EXASExact Sciences$51.55+9.3%4.5006 of 5 stars2.95$70.90 37.5%22Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap UpHigh Trading Volume2.73%REGNRegeneron Pharmaceuticals$605.61+2.6%4.832 of 5 stars2.88$892.60 47.4%26Earnings ReportDividend AnnouncementHigh Trading Volume2.69%LEGNLegend Biotech$33.17-2.3%2.6587 of 5 stars2.92$78.82 137.6%12Positive News2.43%MASIMasimo$166.42+1.7%3.6393 of 5 stars2.83$194.80 17.1%6Upcoming Earnings2.42%SYKStryker$378.60+1.2%4.7918 of 5 stars2.79$426.53 12.7%19Earnings ReportAnalyst ForecastAnalyst RevisionPositive NewsHigh Trading Volume2.40%EWEdwards Lifesciences$75.57+0.5%4.6232 of 5 stars2.42$79.45 5.1%24Short Interest ↓Positive News2.37%LFSTLifeStance Health Group$6.80+4.3%1.3757 of 5 stars2.67$8.30 22.1%6Upcoming Earnings2.21%AGLagilon health$4.16+5.9%1.7866 of 5 stars2.11$4.81 15.6%18Upcoming Earnings2.07%INSPInspire Medical Systems$159.89+1.3%4.8543 of 5 stars2.70$218.90 36.9%101.91%LLYEli Lilly and Company$825.10+3.9%4.9197 of 5 stars2.81$1,002.80 21.5%21Earnings ReportAnalyst ForecastAnalyst RevisionGap Up1.84%DXCMDexCom$81.62+16.2%4.6669 of 5 stars2.95$99.22 21.6%20Earnings ReportAnalyst ForecastAnalyst RevisionGap UpHigh Trading Volume1.54%PRVAPrivia Health Group$23.32+1.8%3.7413 of 5 stars3.07$27.38 17.4%14Upcoming EarningsInsider TradeShort Interest ↓1.50%TMOThermo Fisher Scientific$423.69+0.9%4.9093 of 5 stars2.81$607.43 43.4%21Short Interest ↑Positive NewsGap Up1.43%RMDResMed$239.84+1.4%4.0572 of 5 stars2.60$258.83 7.9%15Analyst UpgradePositive News1.38%DOCSDoximity$59.26+2.0%3.2382 of 5 stars2.57$65.39 10.3%21Insider TradeNews CoveragePositive News1.34%ZLABZai Lab$31.18+0.1%2.4082 of 5 stars2.75$47.37 51.9%4Upcoming EarningsNews Coverage1.28%ASNDAscendis Pharma A/S$172.06+2.7%2.1246 of 5 stars2.93$211.40 22.9%15Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume1.26%CRNXCrinetics Pharmaceuticals$33.76+0.7%3.7546 of 5 stars2.92$73.00 116.2%13Upcoming EarningsPositive News1.26%MRUSMerus$44.19-2.8%3.3732 of 5 stars3.13$85.31 93.0%16Upcoming EarningsShort Interest ↓1.23%PHRPhreesia$25.67+1.7%3.5991 of 5 stars3.00$31.33 22.1%12Short Interest ↑News CoveragePositive News1.17%XENEXenon Pharmaceuticals$38.28+0.5%2.771 of 5 stars3.00$56.78 48.3%10Upcoming EarningsAnalyst DowngradeNews CoveragePositive NewsHigh Trading Volume1.04%PRCTPROCEPT BioRobotics$55.62+5.2%2.719 of 5 stars2.86$90.00 61.8%71.00%CYTKCytokinetics$37.35-13.0%4.029 of 5 stars2.89$76.88 105.8%19Upcoming EarningsAnalyst ForecastInsider TradeOptions VolumeNews CoverageGap DownHigh Trading Volume0.98%GKOSGlaukos$87.60+4.9%4.7398 of 5 stars2.77$137.62 57.1%13Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume0.95%MLTXMoonLake Immunotherapeutics$42.32+2.1%1.654 of 5 stars3.00$80.50 90.2%8Upcoming EarningsAnalyst ForecastNews CoveragePositive News0.93%ALGNAlign Technology$179.82+1.7%4.3919 of 5 stars2.67$241.25 34.2%15Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage0.89%JANXJanux Therapeutics$32.88+2.6%3.1572 of 5 stars3.09$95.25 189.7%11Upcoming EarningsInsider TradeNews CoveragePositive News0.87%VCYTVeracyte$30.35+2.2%3.9918 of 5 stars2.70$42.60 40.4%10Upcoming EarningsShort Interest ↑News CoveragePositive NewsHigh Trading Volume0.82%BRKRBruker$40.44+2.8%4.9807 of 5 stars2.55$65.00 60.7%11Upcoming EarningsShort Interest ↓Positive NewsHigh Trading Volume0.78%ASTHAstrana Health$32.49+3.3%3.3323 of 5 stars2.80$53.29 64.0%10Upcoming EarningsPositive News0.74%TNDMTandem Diabetes Care$21.48+7.5%4.6513 of 5 stars2.53$39.81 85.3%17Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage0.71%KMTSKestra Medical Technologies$23.75+3.4%N/A2.83$27.50 15.8%6Positive News0.67%WSTWest Pharmaceutical Services$211.27+0.5%4.6558 of 5 stars3.00$332.50 57.4%80.66%PCVXVaxcyte$35.39+0.4%2.8628 of 5 stars3.10$136.50 285.7%10Upcoming EarningsNews CoveragePositive News0.65%DYNDyne Therapeutics$11.86-1.1%3.3703 of 5 stars3.07$47.46 300.2%15Short Interest ↑News CoveragePositive News0.60%IRTCiRhythm Technologies$131.12+20.7%0.9717 of 5 stars2.91$128.55 -2.0%11Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap UpHigh Trading Volume This page (NASDAQ:FMED) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredU.S. Stock Market Now on Verge of CollapseThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fidelity Disruptive Medicine ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Fidelity Disruptive Medicine ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy FMED Stock Free FMED Stock Alerts